Business
Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026
BOSTON, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that it will host a live conference call and webcast at 8 a.m. ET on Thursday, February 26, 2026 to report its fourth quarter and full year 2025 financial results and provide a corporate update. To access the live conference call, participants may register
About this update from Rhythm Pharmaceuticals, Inc.
[{"type":"image","alt":"Rhythm Pharmaceuticals, Inc.","displaySize":"","headline":null,"caption":"Rhythm Pharmaceuticals, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":105,"url":"https://media.zenfs.com/en/globenewswire.com/6c26dd8fa407cbf7aa92759a8a5fb54c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/AurFDXSTd0Q12WnAaUwFIg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0NztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/6c26dd8fa407cbf7aa92759a8a5fb54c","width":300,"height":105}},"lazy":false},{"type":"text","content":"BOSTON, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that it will host a live conference call and webcast at 8 a.m. ET on Thursday, February 26, 2026 to report its fourth quarter and full year 2025 financial results and provide a corporate update.","length":437,"tagName":"p"},{"type":"text","content":"To access the live conference call, participants may register here. While not required, it is recommended that participants join the call ten minutes prior to the scheduled start.","length":184,"tagName":"p"},{"type":"text","content":"Also today, Rhythm announced that David Meeker, M.D., Chair, President and Chief Executive Officer, will participate in a fireside chat at the TD Cowen 46th Annual Health Care Conference in Boston on Monday, March 2, 2026, at 11:10 a.m. ET.","length":260,"tagName":"p"},{"type":"text","content":"Live webcasts of both the financial results conference call and the fireside chat will be available under "Events and Presentations" in the Investor Relations section of the Rhythm Pharmaceuticals website at http://ir.rhythmtx.com/. The archived webcast of the financial results conference call will be available on Rhythm’s website approximately two hours after it concludes and will be available for 30 days following the call. A replay of the TD Cowen webcast will also be available on the Rhythm website for 30 days following the presentation.","length":557,"tagName":"p"},{"type":"text","content":"About Rhythm Pharmaceuticals Rhythm is a commercial-stage biopharmaceutical company committed to transforming the lives of patients and their families...